Japanese Drug Maker Head Paid Most Of Reporting Firms So Far
This article was originally published in PharmAsia News
Executive SummaryThe head of Japanese drug maker Nihon Chouzai is the highest-paid executive of a Japanese company that has released financial reports so far
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.